Recent evidence suggests that there are age-related neurocognitive implications for fragile X premutation carriers, including deficits in executive function, and that such deficits are more common in male than female premutation carriers. The purpose of the current study is to examine one aspect of executive function, language dysfluencies, in a group of 193 women with the premutation, and to contrast them with a comparison group (mothers of children with autism spectrum disorders). Our results demonstrate a linguistic profile in the female premutation carriers characterized by dysfluencies associated with deficits in organization and planning, with a clear impact of age. The comparison group, matched on both age and education level, did not demonstrate the age effect. Our results suggest dysfluencies could be an early indicator of cognitive aging in some female premutation carriers, and could be used to target early intervention.
Introduction
The FMR1 gene is associated with a continuum of clinical involvement including fragile X syndrome (FXS), fragile X-associated tremor ataxia syndrome (FXTAS), and fragile X primary ovarian insufficiency (FXPOI). These syndromes occur when there is a defect in the FMR1 gene, located on the long arm of the X chromosome (Verkerk et al., 1991) . The gene is located in the 5 0 untranslated region (locus Xq27.3). FMR1 directs cells to produce the fragile X mental retardation protein (FMRP), which is believed to play an important role in typical brain development and functioning (Darnell, Warren, & Darnell, 2004; Rogers, Wehner, & Hagerman, 2001 ). The FMR1 gene is made up of trinucleotide (CGG) repeats, and elevated repeats beyond 55 signify either the premutation (55-200 repeats) or the full mutation (>200 repeats).
Specifically, the full mutation of fragile X syndrome is a neurodevelopmental disorder, and the most common cause of inherited intellectual disability. It occurs when an individual has more than 200 repeats, thus signifying the full mutation (Bailey, Hatton, Skinner, & Mesibov, 2001; Hagerman, 2002) . In the case of the full mutation, the elevated repeat sequence reduces or shuts down the methylation of FMRP. However, in most individuals with the premutation, FMRP levels are within normal limits, although FMR1 mRNA levels are between 2 and 10 times what is seen in unaffected individuals (Tassone, Hagerman, Chamberlain, & Hagerman, 2000; Tassone et al., 2000) .
The full mutation is relatively rare, affecting approximately 1 in every 2500 males, and 1 in every 4000-6000 females (Crawford, Acuna, & Sherman, 2001; Fernandez-Carvajal et al., 2009; Hagerman, 2008) . However, the premutation is much more common, with 1 in every 260-813 males and 1 in every 113-259 females estimated to have the premutation (Hagerman, 2008) . A recent paper reported the first population-based US study of the prevalence of the premutation, which found that 1 in 151 females and 1 in 468 males had the premutation (Seltzer, Barker, and Hong et al., 2012; Seltzer, Barker and Greenberg et al., 2012) . Whereas initially, premutation carriers were believed to be unaffected, within the last ten years, research has uncovered the impact of the premutation, including early menopause in 20-28% of premutation carrier women (FXPOI), and a late-onset neurodegenerative disorder (FXTAS), which affects approximately 40% of male and 8% of female premutation carriers (Jacquemont et al., 2004) . FXTAS is associated with tremors, gait ataxia, short-term memory and executive function impairments (Bourgeois et al., 2009) .
Both males and females with the premutation have been found to have clinical risk. Recent research has indicated that there is an aging-related set of cognitive symptoms that are associated with the premutation in males, resulting in either FXTAS or a milder phenotype (Cornish et al., 2008; Hay, 2008; Kogan & Cornish, 2010) . Notably, impairments in working memory and executive function starting in the 30 s are associated with greater risk for FXTAS (Brega et al., 2008) . Kogan and Cornish (2010) examined executive function in asymptomatic male premutation carriers. A subset of their participants had clinically significant elevations in everyday working memory, with IQs in the average range. The authors note a cognitive profile of executive dysfunction within
